healthFeb 13, 20266:47pending
Genotype-Guided vs. Conventional P2Y12 Inhibitors in ACS | JACC: CV Interventions | JACC: Cardiovascular Interventions
About this episode
Mirza Umair Khalid, MD, Social Media Editor for JACC: Cardiovascular Interventions, and Mattio Galli, MD, PhD, discuss a recently published original research paper analyzing the role of genotype-guided escalation or de-escalation of antiplatelet therapy in acute coronary syndrome (ACS).
Get every episode summarized
Each time JACC Specialty Journals publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from JACC Specialty Journals
Development of a Predictive Tool in Patients With High Pretest Probability for T...
JACC Specialty Journals
Apr 22, 20263:24completed
Valvular Heart Diseases in Swedish Males and Females: A National Cohort Study |...
JACC Specialty Journals
Apr 22, 20262:22completed
Cardiovascular-Kidney-Metabolic Syndrome and Life Expectancy in U.S. Adults | JA...
JACC Specialty Journals
Apr 22, 20262:48completed
Remote Management of Patients With Heart Failure in Medically Underserved Areas...
JACC Specialty Journals
Apr 22, 20262:42completed